Chest Rub

Description

No description information is available for the specified drug.

Uses and Indications

This drug is indicated for the temporary relief of cough due to the common cold when applied to the chest and throat. Additionally, it is indicated for the temporary relief of minor aches and pains when applied to muscles and joints.

Limitations of Use: There are no known teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

For adults and children aged 2 years and older, a thick layer of the product should be applied to the chest and throat or directly onto sore, aching muscles. If desired, the area may be covered with a warm, dry cloth to enhance the effect. It is recommended to keep clothing loose around the throat and chest to facilitate the release of vapors to the nose and mouth. This application may be repeated up to three times within a 24-hour period, or as directed by a healthcare professional.

For children under 2 years of age, it is advised to consult a doctor before use.

Contraindications

The product is contraindicated for oral administration. It should not be applied with tight bandages, in the nostrils, or on wounds or damaged skin. These restrictions are in place to prevent potential adverse effects associated with improper use.

Warnings and Precautions

For external use only; direct contact with the eyes must be avoided to prevent irritation or injury.

In the event of accidental ingestion, it is imperative to seek immediate medical assistance or contact a Poison Control Center. Prompt action is crucial to ensure patient safety.

Healthcare professionals should advise patients to discontinue use and consult a physician if muscle aches and pains persist for more than 7 days or if they recur. Additionally, patients should be instructed to stop use and seek medical advice if a cough lasts longer than 7 days, returns, or is accompanied by fever, rash, or a persistent headache, as these symptoms may indicate a serious underlying condition.

Emergency medical help should be sought without delay in cases of accidental ingestion, reinforcing the importance of immediate intervention in such scenarios.

Side Effects

Patients using this product should be aware that it is for external use only and must avoid contact with the eyes.

In clinical practice, patients are advised to stop use and consult a healthcare professional if muscle aches and pains persist for more than 7 days or if they recur. Additionally, if a cough lasts more than 7 days, returns, or is accompanied by fever, rash, or a persistent headache, it may indicate a serious condition, and medical advice should be sought.

Before using this product, patients should consult a doctor if they have a cough that occurs with excessive phlegm (mucus) or if they experience a persistent or chronic cough, such as that associated with smoking, asthma, or emphysema.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there is no information available regarding interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Chest Rub (camphor, eucalyptus oil, menthol). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 2 years of age should consult a healthcare professional before use. For children aged 2 years and older, the recommended application involves rubbing a thick layer on the chest and throat or on sore, aching muscles. It is advised to cover the area with a warm, dry cloth if desired and to keep clothing loose around the throat and chest to facilitate the release of vapors. This application may be repeated up to three times within a 24-hour period or as directed by a healthcare provider.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any adverse effects or changes in therapeutic response, given the lack of targeted data for this population.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional prior to using this medication. The potential risks and benefits must be carefully weighed, as the effects on fetal outcomes and lactation are not fully established. It is essential for women of childbearing potential to seek medical advice to ensure safe use during pregnancy and lactation.

Lactation

Lactating mothers are advised to consult a health professional prior to using this medication. There is currently no available data on the excretion of this medication in human breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating individuals.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific overdosage information, it is essential for healthcare professionals to remain vigilant and prepared for potential scenarios involving overdose.

Healthcare providers should be aware that the clinical presentation of an overdose may vary significantly depending on the substance involved and the individual patient’s characteristics. Symptoms of overdose can range from mild to severe and may include alterations in consciousness, respiratory distress, cardiovascular instability, and gastrointestinal disturbances.

In the event of suspected overdosage, immediate medical evaluation is recommended. Healthcare professionals should assess the patient's vital signs and conduct a thorough clinical examination. Supportive care should be initiated as necessary, which may include airway management, oxygen supplementation, and intravenous fluids.

If specific antidotes or treatments are available for the substance involved, they should be administered according to established protocols. Continuous monitoring of the patient’s condition is crucial, and healthcare providers should be prepared to implement advanced life support measures if indicated.

In all cases of suspected overdose, it is advisable to contact a poison control center or consult relevant clinical guidelines for further management recommendations. Documentation of the incident and any interventions performed is also critical for ongoing patient care and safety.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data in these areas limits the understanding of the compound's potential effects in nonclinical settings.

Postmarketing Experience

Adverse reactions associated with the use of Equaline medicated chest rub have been reported through voluntary reporting and surveillance programs. Specific details regarding these reactions are not provided in the insert.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical assistance or contact a Poison Control Center in the event of accidental ingestion of the medication. It is important for patients to understand the potential risks associated with unintentional consumption and the necessity of prompt action to ensure their safety.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It is essential to store the product at room temperature to maintain its integrity and efficacy. Proper storage conditions should be observed to ensure optimal performance.

Additional Clinical Information

The product is administered topically, with specific instructions for different age groups. For adults and children aged 2 years and older, a thick layer should be applied to the chest and throat or sore, aching muscles. It is recommended to cover the area with a warm, dry cloth if desired and to keep clothing loose around the throat and chest to facilitate the inhalation of vapors. This application can be repeated up to three times within a 24-hour period or as directed by a healthcare professional. For children under 2 years of age, consultation with a doctor is advised before use.

No additional information is available regarding laboratory tests, abuse potential, patient counseling, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Chest Rub, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)